📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 17:04
95 analysed today
FollowTelegram
95
Today
150,046
All-time analysed
43,005
Positive
6,671
Negative
91,649
Neutral
8,653
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
June Industries Reports Rs 14.46 Lakhs Net Profit in Q1 FY27, Turning Around from YoY Loss
June Industries (formerly Kashyap Tele-Medicines) reported a net profit of Rs 14.46 Lakhs for the quarter ended June 30, 2026, a significant turnaround from a loss of Rs 2.98 Lakhs in the same period last year. Revenue from operations reached Rs 20.00 Lakhs, compared to zero revenue in the year-ago quarter. This quarterly revenue alone matches the company's total revenue for the entire previous financial year (FY26). Total expenses were sharply reduced to Rs 5.70 Lakhs from Rs 49.31 Lakhs in the preceding March 2026 quarter, aiding the return to profitability.
Confidence: HIGH
What changedThe company has successfully generated revenue and profit in its first quarter of FY27 following a name change and business pivot, moving away from a zero-revenue base in the previous year's corresponding quarter.
Why it mattersThis represents a fundamental shift from a dormant/loss-making entity to an active trading business, although the absolute scale remains extremely small for the broader market.
Revenue (Q1 FY27): Rs 20.00 LakhsNet Profit (Q1 FY27): Rs 14.46 LakhsQ1 Revenue vs FY26 Total Revenue: 100%Total Expenses: Rs 5.70 LakhsEPS: Rs 0.030
📅 Short termThe turnaround to profitability and revenue growth from a zero base is likely to be viewed positively by the market in the short term.
📈 Long termThe long-term outlook depends on the company's ability to scale its pharmaceutical hygiene trading business beyond the current micro-scale operations.
⚠ Risk flags
- Extremely small scale of operations
- High Price-to-Book ratio (156.1)
- Micro-cap liquidity risk
Key Highlights
Revenue from operations grew to Rs 20.00 Lakhs from Rs 0.00 Lakhs in the year-ago quarter.
Net profit stood at Rs 14.46 Lakhs vs a loss of Rs 2.98 Lakhs in June 2025.
Total expenses decreased by 88% sequentially to Rs 5.70 Lakhs from Rs 49.31 Lakhs in March 2026.
Earnings Per Share (EPS) turned positive at Rs 0.030 compared to negative Rs 0.006 YoY.
The company transitioned its focus to trading pharmaceutical hygiene and cleanroom products.
👀 What to Watch
Investors should monitor the sustainability of this new revenue stream in the pharmaceutical hygiene segment over the next 2-3 quarters. Given the micro-cap nature (Rs 28 Cr) and high P/B ratio, execution consistency is critical.
June Industries reports Rs 14.46 Lakhs Net Profit in Q1 FY27, turning around from YoY loss
June Industries reported a revenue of Rs 20.00 Lakhs for Q1 FY27, which effectively matches its entire revenue for the full year FY26 (Rs 19.70 Lakhs). The company achieved a net profit of Rs 14.46 Lakhs, a significant turnaround from a loss of Rs 2.98 Lakhs in the year-ago period and a loss of Rs 27.98 Lakhs in the preceding quarter. This profitability was aided by a sharp 90% QoQ reduction in 'Other Expenses' to Rs 4.78 Lakhs. The company is currently focused on a single segment: trading of pharmaceutical hygiene and cleanroom products.
Confidence: HIGH
What changedThe company has transitioned from a loss-making entity with negligible revenue to reporting a profitable quarter with revenue exceeding its previous full-year performance.
Why it mattersFor a micro-cap with a market capitalization of only Rs 28 Cr, achieving profitability and establishing a revenue stream in its new business segment (pharmaceutical hygiene trading) is a critical milestone for survival and potential growth.
Revenue (Q1 FY27): Rs 20.00 LakhsNet Profit (Q1 FY27): Rs 14.46 LakhsQ1 Revenue vs FY26 Annual Revenue: 101.5%Total Expenses (Q1 FY27): Rs 5.70 LakhsPaid-up Equity Capital: Rs 477.22 Lakhs
📅 Short termThe stock may see positive sentiment as the company has turned profitable on a quarterly basis with a visible revenue jump.
📈 Long termThe long-term outlook remains speculative given the extremely small scale of operations and the high Price-to-Book ratio of 156.1.
⚠ Risk flags
- Extremely small revenue base
- High valuation relative to book value
- Concentration in a single trading segment
Key Highlights
Revenue from operations reached Rs 20.00 Lakhs in Q1 FY27 compared to zero revenue in Q1 FY26
Net profit of Rs 14.46 Lakhs recorded against a net loss of Rs 27.98 Lakhs in Q4 FY26
Total expenses dropped significantly to Rs 5.70 Lakhs from Rs 49.31 Lakhs in the previous quarter
Q1 FY27 revenue (Rs 20 Lakhs) represents approximately 101.5% of the total FY26 annual revenue
Earnings Per Share (EPS) turned positive at 0.030 for the quarter
👀 What to Watch
Investors should monitor if the company can maintain this quarterly revenue run rate and whether the sharp reduction in operating expenses is sustainable or due to one-time accounting adjustments.
